Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast and Their Association With the Clinicopathological Prognostic Paremeters

NCT05703815 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.

NCT NCT05703815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05703815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast and Their Association With the Clinicopathological Prognostic Paremeters
Lead sponsor
Sohag University
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2023
Completion date
March 31, 2023
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

invasive breast cancer